Archives
Transmission Dynamics of Carbapenemase Genes in CREC in Guan
Transmission Dynamics of Carbapenemase-Encoding Genes in CREC: Insights from Eight Hospitals in Guangdong
Study Background and Research Question
Carbapenem-resistant Enterobacter cloacae (CREC) has surfaced as a formidable threat within healthcare settings worldwide, with its clinical significance rising notably in China. The ongoing COVID-19 pandemic has contributed additional complexity, affecting antibiotic usage patterns and healthcare delivery. Increased empirical antibiotic use, disruptions in routine infection control, and the management of complex, co-infected patients have all created fertile ground for the emergence and transmission of drug-resistant organisms. Despite these risks, detailed, multicentric investigations into the genetic mechanisms underpinning carbapenem resistance—specifically the occurrence and spread of carbapenemase-encoding genes (CEGs)—in CREC populations during this period remain scarce. Chen et al. (2025) addressed this gap by characterizing the genetic landscape and transmission dynamics of CEGs across eight teaching hospitals in Guangdong Province, China, from December 2022 to June 2024 (reference study).
Key Innovation from the Reference Study
The principal innovation of Chen et al. lies in their large-scale, multicenter profiling of CEGs in CREC isolates, performed during a period of heightened antimicrobial pressure induced by the pandemic. This study is among the first to systematically map the chromosomal and plasmid locations of clinically relevant CEGs—primarily focusing on blaNDM-1, blaIMP, and blaKPC-2—and to quantify their horizontal and vertical transmission capabilities in actual hospital settings. Their findings provide nuanced insights into the molecular epidemiology of multidrug resistance in CREC, especially the critical role of plasmids as vehicles for rapid gene dissemination.
Methods and Experimental Design Insights
Chen et al. collected 54 non-duplicate CREC isolates from eight teaching hospitals, representing a diverse clinical spectrum. The study utilized a combination of variable temperature Sodium Dodecyl Sulfate (SDS) plasmid elimination, polymerase chain reaction (PCR) assays, and the broth microdilution method to:
- Detect and localize CEGs (blaNDM-1, blaIMP, blaKPC-2) on plasmids and chromosomes.
- Assess antimicrobial resistance profiles of CEG-positive and -negative strains.
- Evaluate the transferability of CEGs through conjugation experiments and PCR-based confirmation.
- Characterize mobile genetic elements (MGEs) such as ISEcp1, which facilitate gene mobility.
- Determine clonal relationships via ERIC-PCR fingerprinting and NTSYS clustering, classifying isolates into 17 genotypes.
By integrating molecular, phenotypic, and epidemiological data, the authors provide a multidimensional view of CREC resistance dynamics.
Protocol Parameters
- Plasmid elimination: Variable temperature SDS treatment to distinguish plasmid-borne versus chromosomal CEGs.
- Bacterial identification and CEG screening: PCR assays targeting blaNDM-1, blaIMP, and blaKPC-2.
- Conjugation efficiency: Broth-based mating protocols; successful transfer confirmed by PCR in recipient strains.
- Antimicrobial susceptibility: Broth microdilution for quantifying resistance to key agents (imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, levofloxacin).
- Genotyping: ERIC-PCR and NTSYS clustering for population structure analysis.
Core Findings and Why They Matter
The study found that 85.19% of CREC isolates carried carbapenemase genes, with blaNDM-1 being the most common. Notably, 33.33% of isolates harbored blaNDM-1 on both chromosomes and plasmids, while 46.30% carried it exclusively on plasmids. A smaller proportion contained blaIMP or a combination of blaNDM-1 and blaKPC-2. CEG-positive strains exhibited significantly higher resistance rates to multiple antibiotics compared to CEG-negative counterparts (see details).
Conjugation experiments demonstrated a strikingly high transferability of these resistance genes—95.65% success overall, with the vast majority involving blaNDM-1. Six types of mobile genetic elements were identified, with ISEcp1 present in 87.04% of isolates, reinforcing the role of MGEs in facilitating horizontal gene transfer.
Genotypic analysis revealed a polyclonal structure, with 17 genotypes detected. The E and G genotypes were most prevalent, distributed across several hospitals and departments. Epidemiological analysis highlighted higher detection rates of CEGs in male and elderly patients, particularly in respiratory medicine and sputum samples. This nuanced mapping of resistance determinants, their vectors, and their population structure informs both local infection control and the broader understanding of how resistance spreads under pandemic-era pressures.
Comparison with Existing Internal Articles
Previous internal analyses, such as "Plasmid-Borne blaNDM-1 Drives Resistance in CREC: Insights from Guangdong", echo the central finding of high plasmid-mediated blaNDM-1 prevalence in CREC within the region, but Chen et al. (2025) expand upon these insights by incorporating detailed transmission dynamics, clonal relationships, and epidemiological risk factors. Similarly, internal reviews such as "Chloramphenicol in Modern Molecular Biology: Mechanisms,..." discuss the role of chloramphenicol as a protein synthesis inhibitor and its use in plasmid selection assays—highlighting the continued importance of robust selection agents in resistance gene studies, a theme mirrored in the reference paper's plasmid transfer and elimination experiments. The synergy between these resources emphasizes the practical need for precise molecular tools and protocols to dissect and monitor resistance dissemination.
Limitations and Transferability
Despite its comprehensive design, the study is limited to eight hospitals within Guangdong province and may not fully capture resistance dynamics in other regions or healthcare environments. The cross-sectional sampling approach, while robust, does not track longitudinal evolution or the impact of specific infection control interventions. Additionally, while the molecular characterization is thorough, not all possible resistance genes or MGEs were targeted.
Nevertheless, the methodologies and analytical frameworks presented—such as the use of PCR for CEG detection, plasmid elimination for gene localization, and conjugation assays—are readily transferable to other settings and organisms. The detailed mapping of plasmid versus chromosomal gene carriage, combined with evidence of high-frequency horizontal transfer, provides a valuable template for similar epidemiological and mechanistic studies elsewhere.
Research Support Resources
For researchers seeking to replicate or extend these workflows, especially in plasmid selection or resistance mechanism studies, high-purity, well-characterized reagents are essential. Chloramphenicol (SKU A2512) is widely used as a bacterial protein synthesis inhibitor and selection marker in molecular biology. Its established mechanism—binding to the 50S ribosomal subunit and blocking translation—makes it a reliable tool for plasmid selection assays and resistance profiling, as discussed in several internal resources. For consistent results, it is critical to select reagents with verified purity and robust performance characteristics.